View Author
cancer screening prostate cancer prostate study group treatment erspc biopsy centre control round cohort european death effect mortality control arm trial result number analysis difference european randomized study reduction value rotterdam control group center contamination incidence screening arm table schr öder fh screening group screening round model prostate-cancer interval roobol university randomized subject psa level urology detection patient cancer detection rate nejm.org randomised england journal psa screening department medicine downloaded erasmus university ratio prostate cancer risk european randomised study study arm koning hj roobol mj estimate 69 years level follow-up antigen netherland life-year copyright prostate cancer screening nonattendance finland utility psa value prostate-cancer mortality men randomised stage journal screen therapy
6 Most Recent Publications
|
Quality-of-life effects of prostate-specific antigen screening
(Article)
Heijnsdijk, E.A.M. Wever, E.M. Zappa, M. Tammela, T.L. Mäkinen, T. Carlsson, S. Korfage, I.J. Essink-Bot, M.L.E. Otto, S.J. Draisma, G. Bangma, C.H. Roobol, M.J. Auvinen, A. Schröder, F.H. Koning, H.J. de Hugosson, J. Ciatto, S. Nelen, V. Kwiatkowski, M. Villers, A. Páez, A. Moss, S.M. |
2012-08-16
|
|
PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
(Article)
Otto, S.J. Moss, S.M. Koning, H.J. de Määttänen, L. Roobol, M.J. Zappa, M. Nelen, V. Kwiatkowski, M. Villers, A. Hugosson, J. Sanchez, A. |
2010-11-01
|
|
The relationship between prostate-specific antigen and prostate cancer risk: The prostate biopsy collaborative group
(Article)
Vickers, A.J. Cronin, A.M. Parekh, D.J. Ankerst, D. Bartsch, G. Klocker, H. Horninger, W. Benchikh, A. Salama, G. Villers, A. Freedland, S.J. Moreira, D.M. Roobol, M.J. Schröder, F.H. Lilja, H. Hugosson, J. Jones, J.S. Kattan, M.W. Klein, E. Hamdy, F. Neal, D. Donovan, J. |
2010-09-01
|
|
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
(Article)
Wolters, T. Roobol, M.J. Nelen, V. Tammela, T.L. Schröder, F.H. Steyerberg, E.W. Bergh, R.C.N. van den Bangma, C.H. Hugosson, J. Ciatto, S. Kwiatkowski, M. Villers, A. Lujan, M. |
2010-05-15
|
|
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
(Article)
Roobol, M.J. Kerkhof, M. Lujan, M. Lilja, H. Zappa, M. Denis, L.J. Recker, F. Berenguer, A. Ruutu, M. Kujala, P.M. Bangma, C.H. Aus, G. Schröder, F.H. Tammela, T.L. Villers, A. Rébillard, X. Moss, S.M. Koning, H.J. de Hugosson, J. Auvinen, A. Cuzick, J. Sasieni, P. Hakama, M. Stenman, U.H. Ciatto, S. Nelen, V. Kwiatkowski, M. |
2009-10-01
|
|
Screening and prostate-cancer mortality in a randomized european study
(Article)
Schröder, F.H. Hugosson, J. Denis, L.J. Recker, F. Määpttänen, A.B. Bangma, C.H. Aus, G. Villers, A. Rébillard, X. Kwast, Th.H. van der Blijenberg, B.G. Moss, S.M. Roobol, M.J. Koning, H.J. de Auvinen, A. Tammela, T.L. Ciatto, S. Nelen, V. Kwiatkowski, M. Lujan, M. Lilja, H. Zappa, M. |
2009-03-26
|
